A neuraminidase potency assay for quantitative assessment of neuraminidase in influenza vaccines

Neuraminidase (NA) immunity leads to decreased viral shedding and reduced severity of influenza disease; however, NA content in influenza vaccines is currently not regulated, resulting in inconsistent quality and quantity of NA that can vary from manufacturer to manufacturer, from year to year, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Byrne-Nash, Rose T., Gillis, Jacob H., Miller, David F., Bueter, Katie M., Kuck, Laura R., Rowlen, Kathy L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6342948/
https://www.ncbi.nlm.nih.gov/pubmed/30675394
http://dx.doi.org/10.1038/s41541-019-0099-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6342948/
https://www.ncbi.nlm.nih.gov/pubmed/30675394
http://dx.doi.org/10.1038/s41541-019-0099-3

Ejemplares similares